Key result
Neutrophil-to-lymphocyte ratio and mean platelet volume predict MACE after STEMI.
Why the study?
Hematological biomarkers have been evaluated as predictors of in-hospital mortality and complications in ACS, but their relationship with short-term clinical outcomes in STEMI treated with primary PCI needed investigation.
Do hematological parameters (NLR, MPV, PDW) predict short-term clinical outcomes in STEMI patients treated with primary PCI?
Population
100 STEMI patients receiving primary PCI
Comparison
Different levels of hematological parameters
Design
Prospective study
Authors
Loading...
NLR and MPV are significant predictors of short-term MACE in STEMI patients undergoing primary PCI, aiding in early risk stratification.
Cohort (n=100)
Do hematological parameters (NLR, MPV, PDW) predict short-term clinical outcomes in STEMI patients treated with primary PCI?
p-value: p=< 0.05
NLR and MPV are significant predictors of short-term MACE in STEMI patients undergoing primary PCI, aiding in early risk stratification.
Nemr et al. (2022) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=100). Hematological parameters (NLR, MPV, PDW) vs. Low vs high values was evaluated on Major adverse cardiovascular events (MACE) (p=< 0.05). Neutrophil-to-lymphocyte ratio and mean platelet volume were significant predictive factors of major adverse cardiovascular events after STEMI (P < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: